LB791 Avacopan, a highly selective small molecule inhibitor of c5a receptor, in patients with Hidradenitis Suppurativa: Initial results from a randomized, double-blind, placebo-controlled, phase 2 study (aurora)
Year: 2021
Type: conference-abstract
Authors: J. Sciacca Kirby, E. Prens, G.B. Jemec, v. Malathong, S. Prasad, T. Schall, P. Staehr, f. Investigators
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3194474366